Ophthalmology Innovation Summit

Ophthalmology Innovation Summit

October 27, 2018
1 min watch
Save

VIDEO: Oyster Point developing nasal spray for dry eye treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO ― At the Ophthalmology Innovation Summit at AAO, Jeffrey Nau, PhD, president and CEO of Oyster Point Pharma, discusses the company’s progress toward the development of a nasal spray targeting the trigeminal nerve to increase tear production in treating dry eye.